Have you or a loved one experienced complications after taking SGLT2 Inhibitors?
We can help! Call (702) 444-4444
Medication/Drug: SGLT2 Inhibitors
- Xigduo XR
Prescribed to lower blood sugar for treatment of Type II Diabetes.
- Cardiac event
- Renal (Kidney) failure
- Diabetic Ketoacidosis
Do the benefits outweigh the risks?
During this first year period, the Institute for Safe Medication Practices (ISMP), a pharmaceutical industry watchdog organization, and publisher of the pharmaceutical industry review Quarterwatch, found 457 “serious adverse events” reported. These serious adverse events ranged from renal failure or impairment, to dehydration, kidney stones, urinary tract infections, to hypersensitivity, which included swelling of the tongue, lips, face or throat, or skin rashes. This review published in the May 2015 edition of Quarterwatch, showed that this drug has a higher number of adverse events reported than 92% of the drugs it regularly watches.
The review concluded that it was uncertain whether this drug does more good than harm over the long term. Other unanswered questions remain, regarding whether long term use of this drug may result in decline in kidney function, increased bone fractures, and increased cardiovascular events.
On May 15, 2015, the FDA released a Safety Communication regarding their finding that SGLT2 inhibitors may cause ketoacidosis. In short the drug may cause high levels of blood acids, known as ketones. This condition is serious enough that the side effects may require hospitalization for several days. The FDA reported that 20 individuals using a SGLT2 inhibitor required emergency room treatment due to diabetic ketoacidosis during the first 15 months Invokana® was on the market.
Ketoacidosis results in symptoms such as difficulty breathing, nausea, vomiting, abdominal pain, confusion, fatigue, and sleepiness. If you are taking Invokana® and are experiencing these symptoms, seek medical help immediately.
Other side effects attributed to Invokana® and SGLT2 inhibitors are:
- Increased urination
- Genital myotic infections
- Urinary tract Infections
- Increased cholesterol levels
GET HELP NOW
INVOKANA/SGLT2 INHIBITOR CASE EVALUATION
Have you or a loved one suffered harm from taking Invokana or an SGLT2 inhibitor? We can help.
Call (702) 444-4444
Nevada Invokana Lawsuit
In answering the question, do the benefits outweigh the risks of any particular drug, it is important to establish what positive outcome is desired from the drug being evaluated. In the case of Invokana®, we are becoming aware of many of its risks before it has become clear that the drug actually delivers the positive outcomes for which it is designed.
One would expect positive outcomes such as reduced incidence of heart attacks and strokes, or reduced risk of impaired vision, kidney, or peripheral nerve damage from a drug treating Type 2 diabetes. At this point, the drug has not been studied long enough to establish whether these outcomes are being improved by this drug. We do know that taking the drug increases risks of ketoacidosis, and increases risks of urinary tract infections, and renal failure, among others.
Richard Harris Law Firm – Representing Nevada Invokana Lawsuits
It is believed that as experience with this medication increases, lawsuits will follow shortly due to the serious side effects which have shown themselves within the first year of use. We want to assist you in this process. If you were prescribed Invokana®, or another SGLT2 inhibitor, and had complications, call our office today for a no cost consultation at (702) 444-4444.
If you took Invokana or an SGLT2 inhibitor, call our law firm? You may be entitled to compensation.
Call (702) 444-4444